Abstract

The RSV-associated disease accounts for a significant health burden particularly in infants and young children who need to be hospitalized. Since continuous surveillance of circulating RSV genotypes is crucial worldwide, this study aimed to investigate the genetic diversity of RSV circulating strains causing upper or lower acute respiratory infection. Our attention was geared towards studying the cases hospitalized or outpatient in children younger than 2 years of age in Iran during 2018/2019. In this study, nasopharyngeal swabs collected from 206 children who presented with respiratory infection symptoms, were admitted to the referral pediatric ward of Bahrami children's hospital in Tehran, Iran. RSV-positive samples were detected via Nested RT-PCR. The glycoprotein gene was sequenced, and virus genotypes were confirmed through phylogenetic analysis by the MEGA X program. A total of 74 (35.92%) samples tested positive for RSV. Among them, sequencing was done in 10 specimens from 2018 (RSV-A: RSV-B=4:6) and 19 specimens from 2019 (RSV-A: RSV-B=16:3). According to phylogenetic analysis, all RSV-A strains were assigned as ON1 genotype and RSV-B strains were assigned as BA9 genotype. A new N-glycosylation site in Iranian BA9 and positive selection in ON1 genotype was observed. Phylogenetic characterization of strains in the current study revealed co-circulation of ON1 and BA9 as the only prevalent genotypes of both RSV-A and –B groups.

Highlights

  • The overwhelming majority of acute lower respiratory infections (ALRI) and hospitalization in early life are caused by the Respiratory syncytial virus (RSV) (Shi et al 2020)

  • Since continuous surveillance of circulating RSV genotypes is critical worldwide, this study aimed to investigate the genetic diversity of RSV circulating strains causing upper or lower acute respiratory infection

  • According to Phylogenetic analysis, all RSV-A strains were assigned as ON1 genotype and RSV-B strains were assigned as BA9 genotype

Read more

Summary

Introduction

The overwhelming majority of acute lower respiratory infections (ALRI) and hospitalization in early life are caused by the Respiratory syncytial virus (RSV) (Shi et al 2020). Newborn infants and young children and people aged > 65 years are more susceptible to develop severe RSV infection (Smithgall et al 2020). RSV infection usually shows mild, cold-like symptoms that recover in a short period, but young children may develop pneumonia or bronchiolitis and it may sometimes cause death (Garcia-Mauriño et al 2019; Fergie et al 2020). Mortality rates in infants hospitalized with RSV are approximately 10 times greater than in infants infected with the influenza virus (Miyairi and DeVincenzo 2008). Multiple contributing factors including environment, pathogen, and the host’s heredity determine susceptibility to pathogens and the course of the disease (Miyairi and DeVincenzo 2008)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call